We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“States are in the best position to enter into global settlements and to protect all communities through statewide implementation of policy and ensuring equitable distribution of available funds,” one brief stated. Read More
The draft claims that in just the first year, drugs accounting for nearly half of all Medicare Part D spending would be subject to negotiation. Read More
Cabaret Biotech filed suit on Monday against Gilead and its Kite Pharma subsidiary alleging that Yescarta its CAR-T immunotherapy for non-Hodgkin’s lymphoma, infringed on its patent (7,741,465) targeting chimeric receptor genes. Read More
The FDA has laid out a three-stage process for how the agency will handle product development and pre-submission meetings for ANDAs, in a new Manual of Policies and Procedures (MAPP) released on Tuesday. Read More
The advocacy group called for the framework to include recommendations from the National Academies of Sciences, Engineering, and Medicines on how to help mitigate the opioid epidemic. Read More
A coalition of unions and advocacy groups is calling on the Federal Trade Commission to investigate AbbVie’s proposed $63 billion acquisition of Allergan for potential anticompetitive behavior — urging it to block the deal if necessary. Read More